ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
New subcutaneous formulation of Tysabri approved in UK
April 19, 2021The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new subcutaneous (SC) formulation for Biogen’s multiple sclerosis treatment Tysabri. -
Par panel reports have persuasive value, not binding: Pharma cos to SC
October 25, 2017The issue whether a parliamentary panel report can be relied upon in judicial proceedings arose over alleged trials of the controversial HPV vaccine by some pharma companies
Pharma Sources Insight January 2025
